Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nice-recommends-mepolizumab-uncontrolled-copd-2026a1000hzz?src=rss
Author :
Publish date : 2026-05-29 14:17:00
Copyright for syndicated content belongs to the linked Source.